Target intelligence / Profile preview

Menin-MLL1 complex

Molecular classification
Histone modification, Transcription factor, Other
01

Overview

The Menin-MLL1 complex is a protein-protein interaction between menin, a scaffold protein encoded by the MEN1 gene, and Mixed Lineage Leukemia 1 (MLL1), a histone H3 lysine 4 (H3K4) methyltransferase that functions as a transcriptional co-activator. Menin tethers MLL1 to chromatin promoters, facilitating assembly of the MLL1 core complex (including WDR5, RbBP5, Ash2L, DPY-30) via the MLL1 Win motif binding to WDR5, which enables mono-, di-, and trimethylation of H3K4 to maintain active gene expression, such as Hox genes. MLL1 is proteolytically processed into MLL-N and MLL-C fragments that reassociate, with domains like CXXC for DNA binding, SET for methyltransferase activity, and motifs for cofactor interactions. The interaction involves MLL1's N-terminal menin-binding motifs (MBM1: MLL4-15, MBM2: MLL23-43) binding menin's deep pocket with high affinity (Kd=6.8 nM). This complex drives leukemogenesis in MLL1-translocated acute leukemias and solid tumors, acting as a therapeutic target for small-molecule inhibitors that block the interface.[1][2][3][5]

Other names
Menin/MLL1 interactionmenin-MLL complexMLL1-menin complex
02

Mechanism of action

Inhibition of menin-MLL1 protein-protein interaction, Disruption of H3K4 methylation, Prevention of MLL1 core complex assembly

03

Biological functions

Transcriptional activationEpigenetic regulationGene expression maintenanceChromatin remodeling
04

Disease associations

CancerLeukemia
05

Interacting drugs

MI-1481

2 more in the full profile.

Beyond the preview

Go deeper on Menin-MLL1 complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Menin-MLL1 complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call